PBA
ARGX icon

Paradigm Biocapital Advisors’s argenx ARGX Stock Holding History

Paradigm Biocapital Advisors’s Portfolio ARGX Stock Details ARGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-59,679
Closed -$35.3M – 29
2025
Q1 		$35.3M Sell
59,679
-421,626
-88% -$266M 1.62% 15
2024
Q4 		$296M Buy
481,305
+931
+0.2% +$546K 10.3% 3
2024
Q3 		$260M Sell
480,374
-57,765
-11% -$29.2M 8.81% 3
2024
Q2 		$231M Sell
538,139
-13,981
-3% -$5.35M 8.86% 2
2024
Q1 		$217M Buy
552,120
+129,543
+31% +$50.2M 7.65% 3
2023
Q4 		$161M Buy
422,577
+161,134
+62% +$75.1M 7.53% 3
2023
Q3 		$129M Buy
261,443
+119,184
+84% +$58.3M 8.72% 2
2023
Q2 		$55.4M Sell
142,259
-38,913
-21% -$15.3M 4.28% 9
2023
Q1 		$67.5M Buy
181,172
+91,616
+102% +$33.9M 6.4% 4
2022
Q4 		$33.9M Sell
89,556
-741
-0.8% -$277K 3.98% 14
2022
Q3 		$31.9M Buy
90,297
+1,481
+2% +$549K 4.25% 10
2022
Q2 		$33.7M Buy
+88,816
New +$28.6M 6.71% 8
2022
Q1 		– Sell
-42,050
Closed -$14.7M – 26
2021
Q4 		$14.7M Buy
+42,050
New +$12.8M 4.21% 11

Other funds holding ARGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Paradigm Biocapital Advisors's ARGX Position: Q2 2025 in Review

Paradigm Biocapital Advisors sold out of argenx (ARGX) in Q2 2025, closing a stake of 59,679 shares — an estimated $35.3M sold.

Paradigm Biocapital Advisors first reported a position in ARGX in Q4 2021 and held it in 13 quarters. The position peaked at $296M in Q4 2024. 437 funds tracked by Wall St. Rank hold ARGX as of Q2 2025.

  • Paradigm Biocapital Advisors reported no remaining argenx position as of Q2 2025 after selling out during the quarter.
  • Paradigm Biocapital Advisors sold 59,679 argenx shares in Q2 2025, an estimated $35.3M.
  • Paradigm Biocapital Advisors first reported a position in argenx in Q4 2021 and held it in 13 quarters.
  • Paradigm Biocapital Advisors's argenx position peaked at $296M in Q4 2024.
  • 437 funds tracked by Wall St. Rank held argenx as of Q2 2025.

Based on Paradigm Biocapital Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.